Literature DB >> 12717443

Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

Atsuo Sasaki1, Takaharu Taketomi, Reiko Kato, Kazuko Saeki, Atsushi Nonami, Mika Sasaki, Masamitsu Kuriyama, Naoaki Saito, Masabumi Shibuya, Akihiko Yoshimura.   

Abstract

The signalling cascade including Raf, mitogen-activated protein kinase (MAPK) kinase and extracellular-signal-regulated kinase (ERK) is important in many facets of cellular regulation. Raf is activated through both Ras-dependent and Ras-independent mechanisms, but the regulatory mechanisms of Raf activation remain unclear. Two families of membrane-bound molecules, Sprouty and Sprouty-related EVH1-domain-containing protein (Spred) have been identified and characterized as negative regulators of growth-factor-induced ERK activation. But the molecular functions of mammalian Sproutys have not been clarified. Here we show that mammalian Sprouty4 suppresses vascular epithelial growth factor (VEGF)-induced, Ras-independent activation of Raf1 but does not affect epidermal growth factor (EGF)-induced, Ras-dependent activation of Raf1. Sprouty4 binds to Raf1 through its carboxy-terminal cysteine-rich domain, and this binding is necessary for the inhibitory activity of Sprouty4. In addition, Sprouty4 mutants of the amino-terminal region containing the conserved tyrosine residue, which is necessary for suppressing fibroblast growth factor signalling, still inhibit the VEGF-induced ERK pathway. Our results show that receptor tyrosine kinases use distinct pathways for Raf and ERK activation and that Sprouty4 differentially regulates these pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717443     DOI: 10.1038/ncb978

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  84 in total

1.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

2.  Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.

Authors:  Keytam S Awad; Jason M Elinoff; Shuibang Wang; Salina Gairhe; Gabriela A Ferreyra; Rongman Cai; Junfeng Sun; Michael A Solomon; Robert L Danner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

3.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

4.  Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2.

Authors:  Cristina de Alvaro; Natalia Martinez; Jose M Rojas; Margarita Lorenzo
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

5.  Targeting oncogenic BRAF in human cancer.

Authors:  Christine A Pratilas; Feng Xing; David B Solit
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

6.  Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.

Authors:  Vanita Vanas; Elsa Mühlbacher; Rosana Kral; Hedwig Sutterlüty-Fall
Journal:  Tumour Biol       Date:  2014-01-09

7.  Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells.

Authors:  James Smith; Rodica P Bunaciu; Gudrun Reiterer; David Coder; Thaddeus George; Michael Asaly; Andrew Yen
Journal:  Exp Cell Res       Date:  2009-03-17       Impact factor: 3.905

8.  Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells.

Authors:  Tony Ly; Aki Endo; Alejandro Brenes; Marek Gierlinski; Vackar Afzal; Andrea Pawellek; Angus I Lamond
Journal:  Wellcome Open Res       Date:  2018-05-02

9.  Loss of Sprouty1 rescues renal agenesis caused by Ret mutation.

Authors:  Esteban J Rozen; Hagen Schmidt; Xavier Dolcet; M Albert Basson; Sanjay Jain; Mario Encinas
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

10.  Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.

Authors:  Sergi Aranda; Mónica Alvarez; Silvia Turró; Ariadna Laguna; Susana de la Luna
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.